$NVAX Updated DD - Bird Flu Bet?

Posted: May 14, 2024

- H5N1 (bird flu) is a concern right now and has recently spread to mammals - Novavax may have something related to H5N1 which could cause their stock to rise - Sanofi paid $1.2 billion for a deal with Novavax, suggesting potential upside for the stock - The poster has a singular $12C EXP. 2026 position in Novavax, believing it could increase in value.





Stay ahead of the market with AI stock alerts & AI summaries of the latest earnings, stock ideas for free with Fluid Bot. Sign up now!